» Articles » PMID: 24491321

Development and Validation of a Brief Dementia Screening Indicator for Primary Care

Overview
Specialties Neurology
Psychiatry
Date 2014 Feb 5
PMID 24491321
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Detection of "any cognitive impairment" is mandated as part of the Medicare annual wellness visit, but screening all patients may result in excessive false positives.

Methods: We developed and validated a brief Dementia Screening Indicator using data from four large, ongoing cohort studies (the Cardiovascular Health Study [CHS]; the Framingham Heart Study [FHS]; the Health and Retirement Study [HRS]; the Sacramento Area Latino Study on Aging [SALSA]) to help clinicians identify a subgroup of high-risk patients to target for cognitive screening.

Results: The final Dementia Screening Indicator included age (1 point/year; ages, 65-79 years), less than 12 years of education (9 points), stroke (6 points), diabetes mellitus (3 points), body mass index less than 18.5 kg/m(2) (8 points), requiring assistance with money or medications (10 points), and depressive symptoms (6 points). Accuracy was good across the cohorts (Harrell's C statistic: CHS, 0.68; FHS, 0.77; HRS, 0.76; SALSA, 0.78).

Conclusions: The Dementia Screening Indicator is a simple tool that may be useful in primary care settings to identify high-risk patients to target for cognitive screening.

Citing Articles

Role of cognitive impairment in predicting the long-term risk of all-cause mortality: a 20-year prospective cohort study in China.

Zhao S, Yang H, Zhao H, Miao M, Wang Q, Wang Y Arch Public Health. 2025; 83(1):27.

PMID: 39905570 PMC: 11796120. DOI: 10.1186/s13690-024-01489-w.


Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and Australia.

Finney C, Brown D, Shvetcov A Transl Psychiatry. 2025; 15(1):15.

PMID: 39837812 PMC: 11751436. DOI: 10.1038/s41398-025-03247-0.


Improving Early Detection of Cognitive Impairment in Older Adults in Primary Care Clinics: Recommendations From an Interdisciplinary Geriatrics Summit.

Hilsabeck R, Perry W, Lacritz L, Arnett P, Shah R, Borson S Ann Fam Med. 2024; 22(6):543-549.

PMID: 39586710 PMC: 11588378. DOI: 10.1370/afm.3174.


Establishing a machine learning dementia progression prediction model with multiple integrated data.

Huang Y, Liu T, Lu C BMC Med Res Methodol. 2024; 24(1):288.

PMID: 39578765 PMC: 11583646. DOI: 10.1186/s12874-024-02411-2.


External validation of dementia prediction models in Black or African American and White older adults: A longitudinal population-based study in the United States.

Dhana K, Barnes L, Beck T, Dhana A, Liu X, Desai P Alzheimers Dement. 2024; 20(11):7913-7922.

PMID: 39394865 PMC: 11567852. DOI: 10.1002/alz.14280.


References
1.
Okura T, Heisler M, Langa K . Association between cognitive function and social support with glycemic control in adults with diabetes mellitus. J Am Geriatr Soc. 2009; 57(10):1816-24. PMC: 2810258. DOI: 10.1111/j.1532-5415.2009.02431.x. View

2.
Hogan D, Bailey P, Black S, Carswell A, Chertkow H, Clarke B . Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. CMAJ. 2008; 179(8):787-93. PMC: 2553866. DOI: 10.1503/cmaj.070803. View

3.
Seshadri S, Fitzpatrick A, Ikram M, DeStefano A, Gudnason V, Boada M . Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010; 303(18):1832-40. PMC: 2989531. DOI: 10.1001/jama.2010.574. View

4.
Barnes D, Alexopoulos G, Lopez O, Williamson J, Yaffe K . Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry. 2006; 63(3):273-9. DOI: 10.1001/archpsyc.63.3.273. View

5.
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J . Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006; 5(9):735-41. DOI: 10.1016/S1474-4422(06)70537-3. View